Recombinant gastric lipase (Meristem)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant gastric lipase (Meristem)
Drug Alias NameMerispase
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionLipase stimulants
TargetsLipase
Therapy Area/IndicationsExocrine Pancreatic Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesVentria Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVentria Bioscience Inc
Active IndicationsN/A
Inactive IndicationsExocrine Pancreatic Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A